Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation
暂无分享,去创建一个
Y. Nakatsuji | S. Tada | S. Sakakibara | H. Fujimura | M. Kinoshita | A. Kumanogoh | Kaori Sakakibara | H. Mochizuki | T. Okuno | T. Sugimoto | H. Sumi | T. Koda | K. Yamashita | T. Ishikura | Mikito Shimizu | H. Murata | S. Beppu | N. Shiraishi | Y. Sugiyama | Satoru Tada
[1] S. Hamada,et al. Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis , 2019, The Journal of allergy and clinical immunology.
[2] Y. Nakatsuji,et al. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder , 2018, Journal of Neuroinflammation.
[3] P. Pfluger,et al. Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice , 2018, Journal of Neuroinflammation.
[4] A. Fournier,et al. IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells , 2018, Proceedings of the National Academy of Sciences.
[5] A. Adamczyk,et al. Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity , 2018, Journal of Neuroinflammation.
[6] J. Takagi,et al. Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus , 2017, Scientific Reports.
[7] S. Weigand,et al. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica , 2017, Acta Neuropathologica.
[8] B. Engelhardt,et al. The movers and shapers in immune privilege of the CNS , 2017, Nature Immunology.
[9] Giuseppe Compagno,et al. Universality of Schmidt decomposition and particle identity , 2016, Scientific Reports.
[10] R. Ellis,et al. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection , 2016, Journal of NeuroVirology.
[11] C. Tan. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2016, Neurology.
[12] K. Fujihara,et al. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody , 2015, Acta Neuropathologica Communications.
[13] E. Fadel,et al. IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis , 2015, Acta neuropathologica communications.
[14] H. Weiner,et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation , 2014, Nature Medicine.
[15] D. Pleasure,et al. Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE , 2014, The Journal of Neuroscience.
[16] C. Lucchinetti,et al. Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures , 2014, Glia.
[17] A. Verkman,et al. Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG , 2014, Acta Neuropathologica.
[18] J. Satoh,et al. Reactive astrocytes and perivascular macrophages express NLRP3 inflammasome in active demyelinating lesions of multiple sclerosis and necrotic lesions of neuromyelitis optica and cerebral infarction , 2013 .
[19] K. Fujihara,et al. Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats , 2013, Acta neuropathologica communications.
[20] M. Mori,et al. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[21] M. Papadopoulos,et al. Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.
[22] D. Legler,et al. Distinct modulation of chemokine expression patterns in human monocyte-derived dendritic cells by prostaglandin E(2). , 2012, Cellular immunology.
[23] R. Gregg,et al. Use of the anti-inflammatory cytokine interleukin-11 to reverse HIV-1gp120 repression of a natural killer cell line. , 2012, Cellular Immunology.
[24] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[25] A. Verkman,et al. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms , 2011, Annals of neurology.
[26] F. Rossi,et al. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool , 2011, Nature Neuroscience.
[27] J. Honnorat,et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. , 2010, Brain : a journal of neurology.
[28] B. Hemmer,et al. Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica , 2009, Annals of neurology.
[29] S. Sakoda,et al. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. , 2009, Biochemical and biophysical research communications.
[30] Y. Abiko,et al. Microarray analysis of IL-1beta-stimulated chemokine genes in synovial fibroblasts from human TMJ. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[31] A. Verkman,et al. The Journal of Experimental Medicine CORRESPONDENCE , 2005 .
[32] A. Bennaceur-Griscelli,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2002 .
[33] Hans Lassmann,et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.
[34] R. van Furth,et al. Effect of lisofylline and pentoxifylline on the bacterial‐stimulated production of TNF‐α, IL‐1β and IL‐10 by human leucocytes , 1997, Immunology.
[35] M. Cybulsky,et al. Neutrophil leukocyte emigration induced by endotoxin. Mediator roles of interleukin 1 and tumor necrosis factor alpha 1. , 1988, Journal of immunology.
[36] K. Kothur,et al. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. , 2016, Cytokine.